Close

Mateon Therapeutics (MATN) Announces Receipt of Cathepsin-Related U.S. Patent

Go back to Mateon Therapeutics (MATN) Announces Receipt of Cathepsin-Related U.S. Patent
(AMEX: MATN) Delayed: 0.26 --0 (-0%)
Previous Close $0.26    52 Week High $0.85 
Open $2.09    52 Week Low $0.45 
Day High $0.26    P/E N/A 
Day Low $0.26    EPS $0.00 
Volume 233,356